Steven A. Rosenberg

2 ta ish

National Cancer Institute

1. Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

   Peter Attia, Ajay V. Maker, Leah Haworth +2

   Maqola20052 iqtibos

   ABIABI:AkademIndex/2026.other.223191

2. Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma

   Ling Zhang, Richard A. Morgan, Joal D. Beane +15

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.801790